help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muller-Hocker, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muller-Hocker, J.

American Journal of Pathology, Vol 134, 1167-1173, Copyright © 1989 by American Society for Investigative Pathology


REGULAR ARTICLES

Cytochrome-c-oxidase deficient cardiomyocytes in the human heart--an age-related phenomenon. A histochemical ultracytochemical study

J Muller-Hocker
Pathologisches Institut Universitat Munchen, West Germany.

Cytochrome-c-oxidase, the terminal enzyme of the respiratory chain, was studied in 140 hearts from men obtained at autopsy revealing randomly distributed cardiomyocytes without enzyme activity. The expression of the defect was independent of an underlying heart disease and was observed both in normal hearts and in hearts with hypertrophy and/or coronary arteriosclerosis. In contrast, age was a discriminating factor: The defects occurred sporadically in the second decade, but were regularly present from the sixth decade on. Also, the number of defects/sq cm (defect density) increased with age from 2 to 3 in the second and third decade, to about 50 defects in advanced age. Irrespective of the defect density, the enzyme defect always affected isolated cardiomyocytes and ended abruptly at the intercalated disc of neighboring heart muscle cells, as revealed by ultracytochemistry. The results indicate that cytochrome-c-oxidase deficient heart muscle cells represent a degenerative lesion associated with cellular ageing and may be involved in the reduction of myocardial contractile ability in senescence.


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
E. Dufour, M. Terzioglu, F. H. Sterky, L. Sorensen, D. Galter, L. Olson, J. Wilbertz, and N.-G. Larsson
Age-associated mosaic respiratory chain deficiency causes trans-neuronal degeneration
Hum. Mol. Genet., May 15, 2008; 17(10): 1418 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. F. Passos, G. Saretzki, and T. von Zglinicki
DNA damage in telomeres and mitochondria during cellular senescence: is there a connection?
Nucleic Acids Res., December 3, 2007; 35(22): 7505 - 7513.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
H.-C. Lee and Y.-H. Wei
Oxidative Stress, Mitochondrial DNA Mutation, and Apoptosis in Aging
Experimental Biology and Medicine, May 1, 2007; 232(5): 592 - 606.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
K. J. KRISHNAN, L. C. GREAVES, A. K. REEVE, and D. M. TURNBULL
Mitochondrial DNA Mutations and Aging
Ann. N.Y. Acad. Sci., April 1, 2007; 1100(1): 227 - 240.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H. Aguilaniu, J. Durieux, and A. Dillin
Metabolism, ubiquinone synthesis, and longevity
Genes & Dev., October 15, 2005; 19(20): 2399 - 2406.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. J. McLean and D. G. Le Couteur
Aging Biology and Geriatric Clinical Pharmacology
Pharmacol. Rev., June 1, 2004; 56(2): 163 - 184.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y.-H. Wei and H.-C. Lee
Oxidative Stress, Mitochondrial DNA Mutation, and Impairment of Antioxidant Enzymes in Aging
Experimental Biology and Medicine, October 1, 2002; 227(9): 671 - 682.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. A. Bua, S. H. McKiernan, J. Wanagat, D. McKenzie, and J. M. Aiken
Mitochondrial abnormalities are more frequent in muscles undergoing sarcopenia
J Appl Physiol, June 1, 2002; 92(6): 2617 - 2624.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. AIKEN, E. BUA, Z. CAO, M. LOPEZ, J. WANAGAT, D. McKENZIE, and S. McKIERNAN
Mitochondrial DNA Deletion Mutations and Sarcopenia
Ann. N.Y. Acad. Sci., April 1, 2002; 959(1): 412 - 423.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
O. A. Kajander, P. J. Karhunen, and H. T. Jacobs
The relationship between somatic mtDNA rearrangements, human heart disease and aging
Hum. Mol. Genet., February 1, 2002; 11(3): 317 - 324.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Z. Cao, J. Wanagat, S. H. McKiernan, and J. M. Aiken
Mitochondrial DNA deletion mutations are concomitant with ragged red regions of individual, aged muscle fibers: analysis by laser-capture microdissection
Nucleic Acids Res., November 1, 2001; 29(21): 4502 - 4508.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. WANAGAT, Z. CAO, P. PATHARE, and J. M. AIKEN
Mitochondrial DNA deletion mutations colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting, and oxidative damage in sarcopenia
FASEB J, February 1, 2001; 15(2): 322 - 332.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Mariani, R. Ou, M. Bailey, M. Rowland, P. Nagley, F. Rosenfeldt, and S. Pepe
Tolerance to ischemia and hypoxia is reduced in aged human myocardium
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 660 - 667.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
Y.-H. WEI, C.-Y. LU, H.-C. LEE, C.-Y. PANG, and Y.-S. MA
Oxidative Damage and Mutation to Mitochondrial DNA and Age-dependent Decline of Mitochondrial Respiratory Function
Ann. N.Y. Acad. Sci., November 20, 1998; 854(1): 155 - 170.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. A. KOVALENKO, G. KOPSIDAS, J. KELSO, F. ROSENFELDT, and A. W. LINNANE
Tissue-specific Distribution of Multiple Mitochondrial DNA Rearrangements during Human Aging
Ann. N.Y. Acad. Sci., November 20, 1998; 854(1): 171 - 181.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Laderman, J. R. Penny, F. Mazzucchelli, N. Bresolin, G. Scarlato, and G. Attardi
Aging-dependent Functional Alterations of Mitochondrial DNA (mtDNA) from Human Fibroblasts Transferred into mtDNA-less Cells
J. Biol. Chem., July 5, 1996; 271(27): 15891 - 15897.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D. Wallace
Mitochondrial genetics: a paradigm for aging and degenerative diseases?
Science, May 1, 1992; 256(5057): 628 - 632.
[Abstract] [PDF]


Home page
Circ. Res.Home page
T.-j. Liu, H.-c. Lai, W. Wu, S. Chinn, and P. H. Wang
Developing a Strategy to Define the Effects of Insulin-Like Growth Factor-1 on Gene Expression Profile in Cardiomyocytes
Circ. Res., June 22, 2001; 88(12): 1231 - 1238.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Society for Investigative Pathology.